This is dose-dependent and often more pronounced at higher levels, but some people experience it even at microdoses
In addition, in the HepG2 cell experiment, some extrahepatic factors, such as erythroid-2-related factor 2 (NRF2) pathway [58], intestinal metabolite sodium butyrate (NaB) [59], Src homology region 2 domain-containing phosphatase-1 (SHP1)/AMPK [60], sirtuin 1 (SIRT1)/heat shock factor 1/heat shock protein (HSP) [61], and other signaling pathways have also been found to be involved in the regulation of liver lipid synthesis
This treatment is especially beneficial for individuals with conditions like type 2 diabetes, high cholesterol, or hypertension
When those pieces align, the research makes a strong case for it
End-stage liver disease (cirrhosis) 4